Rchr

J-GLOBAL ID：201901016076647916 Update date: Jan. 30, 2024

Masatoshi Nishizawa

ニシザワマサトシ | Masatoshi Nishizawa

Affiliation and department：

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (1)：

2020 - 2023 疲弊化T細胞のシングルセルオミックス解析とリプグラミングによるT細胞疲弊の克服

Papers (15)：

Kawaguchi K, Nakano K, Urasaki T, Fukuda N, Taira S, Ono M, Tomomatsu J, Nishizawa M, Ae K, Matsumoto S, et al. Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma. In vivo (Athens, Greece). 2019. 33. 5. 1609-1614
Masatoshi Nishizawa, Kazuhisa Chonabayashi, Masaki Nomura, Azusa Tanaka, Masahiro Nakamura, Azusa Inagaki, Misato Nishikawa, Ikue Takei, Akiko Oishi, Koji Tanabe, et al. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity. CELL STEM CELL. 2016. 19. 3. 341-354
Masato Nakagawa, Yukimasa Taniguchi, Sho Senda, Nanako Takizawa, Tomoko Ichisaka, Kanako Asano, Asuka Morizane, Daisuke Doi, Jun Takahashi, Masatoshi Nishizawa, et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. SCIENTIFIC REPORTS. 2014. 4. 3594
Yuji Nakamoto, Kensuke Kurihara, Masatoshi Nishizawa, Kouhei Yamashita, Koya Nakatani, Tadakazu Kondo, Akifumi Takaori-Kondo, Kaori Togashi. Clinical value of C-11-methionine PET/CT in patients with plasma cell malignancy: comparison with F-18-FDG PET/CT. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013. 40. 5. 708-715
西澤正俊, 山下浩平, 高折晃史, 中本裕士. 多発性骨髄腫の画像診断法の進歩--PET検査を中心に. 医学のあゆみ. 2012. 242. 13. 1045-1050

ｍore...

MISC (5)：

Kazuhisa Chonabayashi, Masahiro Kawahara, Akira Watanabe, Masahiro Nakamura, Masatoshi Nishizawa, Akifumi Takaori-Kondo, Shinya Yamanaka, Yoshinori Yoshida. Ips Technology Revealed the Genetic and Functional Diversity Present in a Secondary AML Patient. BLOOD. 2016. 128. 22
Kazuhisa Chonabayashi, Masahiro Kawahara, Keisuke Okita, Masatoshi Nishizawa, Norimitsu Kadowaki, Akifumi Takaori-Kondo, Shinya Yamanaka, Yoshinori Yoshida. Patient-Specific Induced Pluripotent Stem Cells Recapitulate the Maturation Defect of Myelodysplastic Syndromes. BLOOD. 2014. 124. 21
Chonabayashi K, Kawahara M, Watanabe A, Amano N, Okita K, Nishizawa M, Kadowaki N, Takaori-Kondo A, Yamanaka S, Yoshida Y. iPS technology revealed the genetic and functional diversity present in a single MDS patient. 臨床血液. 2014. 55. 9. 1259
Chonabayashi K, Kawahara M, Watanabe A, Okita K, Nishizawa M, Kadowaki N, Takaori-Kondo A, Yamanaka S, Yoshida Y. Search for pathogenesis of acquired myelodysplastic syndromes using reprogramming technology. 第75回日本血液学会学術集会. 2013. 54. 9. 1102
岡本浩平, 菱澤方勝, 西澤正俊, 蝶名林和久, 金子仁臣, 渡邊光正, 通堂満. 骨髄非破壊的同種造血幹細胞移植を行った末梢性T細胞リンパ腫の2例. 臨床血液. 2006. 47. 9. 1201-1201

Lectures and oral presentations (11)：

ニボルマブの著効例に急激に発症した無顆粒球症
(第16回日本臨床腫瘍学会学術総会 2018)
Landscape of molecular signatures and hematopoietic differentiation capacity of human iPS cells
(2015)
Landscape of Transcriptional and Epigenetic Profile and Hematopoietic Differentiation Capacity of Human Pluripotent Stem Cells
(International Society for Stem Cell Research (ISSCR) 13th Annual Meeting 2015)
Differentiation phase-dependent factors responsible for variation in hematopoietic differentiation propensity among human pluripotent stem cells revealed by genome-wide analysis of gene expression and DNA methylation.
(International Society for Stem Cell Research (ISSCR) 12th Annual Meeting 2014)
Comprehensive comparison of gene expression, genomic DNA methylation, and in vitro hematopoietic differentiation among many human iPS and ES cell lines
(55th The American Society of Hematology Annual Meeting and Exposition 2013)

ｍore...

Professional career (1)：

博士(医学) (京都大学)

Awards (1)：

2013/12 - American Society of Hematology Abstract Achievement Award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM